299 related articles for article (PubMed ID: 26093840)
1. Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation.
Jochheim D; Zadrozny M; Theiss H; Baquet M; Maimer-Rodrigues F; Bauer A; Lange P; Greif M; Kupatt C; Hausleiter J; Hagl C; Massberg S; Mehilli J
EuroIntervention; 2015 Jun; 11(2):214-20. PubMed ID: 26093840
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.
Nijhoff F; Abawi M; Agostoni P; Ramjankhan FZ; Doevendans PA; Stella PR
Circ Cardiovasc Interv; 2015 Jun; 8(6):e002408. PubMed ID: 26033967
[TBL] [Abstract][Full Text] [Related]
3. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of prosthesis-patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve.
Miyasaka M; Tada N; Taguri M; Kato S; Enta Y; Hata M; Watanabe Y; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Ueno H; Mizutani K; Tabata M; Takagi K; Yamamoto M; Hayashida K;
Open Heart; 2021 Mar; 8(1):. PubMed ID: 33737333
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation.
Ferrante G; Pagnotta P; Petronio AS; Bedogni F; Brambilla N; Fiorina C; Giannini C; Mennuni M; De Marco F; Klugmann S; Ettori F; Presbitero P
Catheter Cardiovasc Interv; 2014 Aug; 84(2):264-71. PubMed ID: 24408011
[TBL] [Abstract][Full Text] [Related]
6. Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.
Binder RK; Stortecky S; Heg D; Tueller D; Jeger R; Toggweiler S; Pedrazzini G; Amann FW; Ferrari E; Noble S; Nietlispach F; Maisano F; Räber L; Roffi M; Grünenfelder J; Jüni P; Huber C; Windecker S; Wenaweser P
Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26453687
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve.
Urena M; Mok M; Serra V; Dumont E; Nombela-Franco L; DeLarochellière R; Doyle D; Igual A; Larose E; Amat-Santos I; Côté M; Cuéllar H; Pibarot P; de Jaegere P; Philippon F; Garcia del Blanco B; Rodés-Cabau J
J Am Coll Cardiol; 2012 Oct; 60(18):1743-52. PubMed ID: 23040577
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world.
Arai T; Lefèvre T; Hovasse T; Morice MC; Garot P; Benamer H; Unterseeh T; Hayashida K; Watanabe Y; Bouvier E; Cormier B; Chevalier B
J Cardiol; 2017 Mar; 69(3):565-569. PubMed ID: 27288330
[TBL] [Abstract][Full Text] [Related]
11. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
[TBL] [Abstract][Full Text] [Related]
12. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
Liang M; Devlin G; Pasupati S
J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
[TBL] [Abstract][Full Text] [Related]
13. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation.
Houthuizen P; van der Boon RM; Urena M; Van Mieghem N; Brueren GB; Poels TT; Van Garsse LA; Rodés-Cabau J; Prinzen FW; de Jaegere P
EuroIntervention; 2014 Feb; 9(10):1142-50. PubMed ID: 24273252
[TBL] [Abstract][Full Text] [Related]
14. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation.
van der Boon RM; Houthuizen P; Urena M; Poels TT; van Mieghem NM; Brueren GR; Altintas S; Nuis RJ; Serruys PW; van Garsse LA; van Domburg RT; Cabau JR; de Jaegere PP; Prinzen FW
Catheter Cardiovasc Interv; 2015 Apr; 85(5):E144-52. PubMed ID: 25504891
[TBL] [Abstract][Full Text] [Related]
15. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation.
Jilaihawi H; Makkar RR
EuroIntervention; 2012 Sep; 8 Suppl Q():Q31-3. PubMed ID: 22995109
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
[TBL] [Abstract][Full Text] [Related]
18. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
[TBL] [Abstract][Full Text] [Related]
19. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
[TBL] [Abstract][Full Text] [Related]
20. Relative amplitude index: a new tool for hemodynamic evaluation of periprosthetic regurgitation after transcatheter valve implantation.
Heinz A; DeCillia M; Feuchtner G; Mueller S; Bartel T; Friedrich G; Grimm M; Mueller LCh; Bonaros N
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1021-8, 1029.e1-2. PubMed ID: 24342900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
